ArticlePoultry science2026
Mulberry leaf powder alleviates fatty liver hemorrhagic syndrome in laying hens via the gut-liver axis and hepatic metabolic regulation.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This experiment was conducted to investigate the effects of mulberry leaf powder (MLP) on alleviating fatty liver hemorrhagic syndrome (FLHS) in laying hens. A total of 180 healthy 33-week-old Hy-Line Gray laying hens were randomly assigned to 3 groups, with 6 replicates per group and 10 chickens per replicate, and fed a basal diet (CON), high-energy-low-protein (HELP) diet (FLHS), and HELP + 5% MLP diet (MLP), respectively. The experiment lasted 56 days. Results showed that the HELP diet successfully induced FLHS, characterized by an increased liver index, hepatic steatosis, and oxidative stress (P < 0.05). MLP significantly alleviated FLHS-induced hepatic steatosis, and enhanced antioxidant capacity (superoxide dismutase, catalase, glutathione peroxidase, total antioxidant capacity, and glutathione) in serum and liver (P < 0.05). Transcriptomic analysis identified 102 differentially expressed genes, whose expression was increased by FLHS but reversed by MLP, including SREBF1, SLC27A4, PLIN2, ACOT13, APOA4, GLRX, and MSRB1, which mainly participate in lipid droplet dynamics and redox homeostasis. qRT-PCR confirmed that upregulated expression of lipogenic genes (such as FASN, ACACA, SCD, and ELOVL6) and the downregulated expression of oxidative stress-responsive genes (SOD1 and GPX1) in the FLHS group were normalized by MLP (P < 0.05), accompanied by increased expression of PPARα, CPT1A, and CD36 (P<0.05). 16S rRNA sequencing revealed that MLP reduced the abundance of Desulfovibrio, Rikenellaceae_RC9_gut_group, Intestinimonas, and Shuttleworthia, and enriched Faecalibacterium and Bifidobacterium in the cecum of FLHS laying hens (P < 0.05). Furthermore, MLP increased acetate, propionate, and butyrate levels, and decreased isobutyrate and isovalerate levels (P < 0.05). Correlation analysis showed that cecal acetate, propionate, butyrate, Faecalibacterium and Bifidobacterium were positively correlated with hepatic antioxidant enzyme activities (P < 0.05), and negatively correlated with hepatic lipogenic gene expression, hepatic lipid deposition and oxidative stress markers (P < 0.05). These findings indicated that MLP alleviated hepatic lipid metabolism disorders and oxidative stress in FLHS laying hens, which might be achieved by modulating gut microbiota structure and short-chain fatty acid production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.